Artículos de revistas sobre el tema "Potent anti-cancer agent"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Potent anti-cancer agent".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Bhat, Smitha S., Shashanka K. Prasad, Chandan Shivamallu, Kollur Shiva Prasad, Asad Syed, Pruthvish Reddy, Charley A. Cull y Raghavendra G. Amachawadi. "Genistein: A Potent Anti-Breast Cancer Agent". Current Issues in Molecular Biology 43, n.º 3 (10 de octubre de 2021): 1502–17. http://dx.doi.org/10.3390/cimb43030106.
Texto completoIbrahim, Mona, Donia Wafaa y Ghada El Nady. "Ginger Extract as Potent Anti-Cancer Agent against Breast Cancer". Journal of Agricultural Chemistry and Biotechnology 13, n.º 12 (1 de diciembre de 2022): 139–43. http://dx.doi.org/10.21608/jacb.2023.183821.1042.
Texto completoSAXENA, B., L. ZHU, M. HAO, E. KISILIS, M. KATDARE, O. OKTEM, A. BOMSHTEYN y P. RATHNAM. "Boc-lysinated-betulonic acid: A potent, anti-prostate cancer agent". Bioorganic & Medicinal Chemistry 14, n.º 18 (15 de septiembre de 2006): 6349–58. http://dx.doi.org/10.1016/j.bmc.2006.05.048.
Texto completoSamuel, Samson, Elizabeth Varghese, Peter Kubatka, Chris Triggle y Dietrich Büsselberg. "Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer". Biomolecules 9, n.º 12 (9 de diciembre de 2019): 846. http://dx.doi.org/10.3390/biom9120846.
Texto completoPurushottamachar, Puranik, Aakanksha Khandelwal, Tadas S. Vasaitis, Robert D. Bruno, Lalji K. Gediya y Vincent C. O. Njar. "Potent anti-prostate cancer agents derived from a novel androgen receptor down-regulating agent". Bioorganic & Medicinal Chemistry 16, n.º 7 (1 de abril de 2008): 3519–29. http://dx.doi.org/10.1016/j.bmc.2008.02.031.
Texto completoSameem, Bilqees, Ebrahim Saeedian Moghadam, Majid Darabi, Zahra Shahsavari y Mohsen Amini. "Triarylpyrazole Derivatives as Potent Cytotoxic Agents; Synthesis and Bioactivity Evaluation “Pyrazole Derivatives as Anticancer Agent”". Drug Research 71, n.º 07 (19 de mayo de 2021): 388–94. http://dx.doi.org/10.1055/a-1498-1714.
Texto completoWatanabe, Coran M. H., Lubica Supekova y Peter G. Schultz. "Transcriptional Effects of the Potent Enediyne Anti-Cancer Agent Calicheamicin γ1I". Chemistry & Biology 9, n.º 2 (febrero de 2002): 245–51. http://dx.doi.org/10.1016/s1074-5521(02)00103-5.
Texto completoTundis, Rosa, Jayanta Kumar Patra, Marco Bonesi, Subrata Das, Rajat Nath, Anupam Das Talukdar, Gitishree Das y Monica Rosa Loizzo. "Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide". Plants 12, n.º 10 (12 de mayo de 2023): 1969. http://dx.doi.org/10.3390/plants12101969.
Texto completoLiu, Weiya, Eugene K. Lee, Karim Pirani, Brian S. J. Blagg y Jeffrey M. Holzbeierlein. "A new HSP90 inhibitor as therapeutic agent for bladder cancer." Journal of Clinical Oncology 35, n.º 6_suppl (20 de febrero de 2017): 416. http://dx.doi.org/10.1200/jco.2017.35.6_suppl.416.
Texto completoRosenthal, Gerald A. "l-Canaline: A potent antimetabolite and anti-cancer agent from leguminous plants". Life Sciences 60, n.º 19 (abril de 1997): 1635–41. http://dx.doi.org/10.1016/s0024-3205(96)00595-4.
Texto completoPardo-Andreu, Gilberto L., Yanier Nuñez-Figueredo, Valeria G. Tudella, Osmany Cuesta-Rubio, Fernando P. Rodrigues, Cezar R. Pestana, Sérgio A. Uyemura, Andréia M. Leopoldino, Luciane C. Alberici y Carlos Curti. "The anti-cancer agent nemorosone is a new potent protonophoric mitochondrial uncoupler". Mitochondrion 11, n.º 2 (marzo de 2011): 255–63. http://dx.doi.org/10.1016/j.mito.2010.10.008.
Texto completoKo, Jeong-Hyeon, Frank Arfuso, Gautam Sethi y Kwang Ahn. "Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy". International Journal of Molecular Sciences 19, n.º 12 (14 de diciembre de 2018): 4048. http://dx.doi.org/10.3390/ijms19124048.
Texto completoBhutia, Sujit K., Birendra Behera, Durgesh Nandini Das, Subhadip Mukhopadhyay, Niharika Sinha, Prashanta Kumar Panda, Prajna Paramita Naik et al. "Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer". International Journal of Cancer 139, n.º 2 (30 de marzo de 2016): 457–66. http://dx.doi.org/10.1002/ijc.30055.
Texto completoKothavade, Pankaj S., Dnyaneshwar M. Nagmoti, Vipin D. Bulani y Archana R. Juvekar. "Arzanol, a Potent mPGES-1 Inhibitor: Novel Anti-Inflammatory Agent". Scientific World Journal 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/986429.
Texto completoDahlem, Charlotte, Wei Xiong Siow, Maria Lopatniuk, William K. F. Tse, Sonja M. Kessler, Susanne H. Kirsch, Jessica Hoppstädter et al. "Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism". Cancers 12, n.º 5 (19 de mayo de 2020): 1288. http://dx.doi.org/10.3390/cancers12051288.
Texto completoRaut, Dattatraya G., Sandeep B. Patil, Vikas D. Kadu, Mahesh G. Hublikar y Raghunath B. Bhosale. "Synthesis of Asymmetric 1-Thiocarbamoyl Pyrazoles as Potent Anti- Colon Cancer, Antioxidant and Anti-Inflammatory Agent". Anti-Cancer Agents in Medicinal Chemistry 18, n.º 15 (28 de febrero de 2019): 2117–23. http://dx.doi.org/10.2174/1871520618666181112122528.
Texto completoSUN, YUAN-WAN, KUEN-YUAN CHEN, CHUL-HOON KWON y KUN-MING CHEN. "CK0403, a 9-aminoacridine, is a potent anti-cancer agent in human breast cancer cells". Molecular Medicine Reports 13, n.º 1 (23 de noviembre de 2015): 933–38. http://dx.doi.org/10.3892/mmr.2015.4604.
Texto completoVarakumar, Potlapati, Kalirajan Rajagopal, Baliwada Aparna, Kannan Raman, Gowramma Byran, Clara Mariana Gonçalves Lima, Salma Rashid, Mohammed H. Nafady, Talha Bin Emran y Sławomir Wybraniec. "Acridine as an Anti-Tumour Agent: A Critical Review". Molecules 28, n.º 1 (26 de diciembre de 2022): 193. http://dx.doi.org/10.3390/molecules28010193.
Texto completoKotlarczyk, Kari, Mario Sepulveda, Tong Wang, Maggie Murray, Paul Gonzales y Stephen Thomas Gately. "Abstract 1359: Selective HDAC6 inhibition by GB-1101 revokes tumor immune privilege and synergizes with immune checkpoint therapies to induce tumor regressions". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1359. http://dx.doi.org/10.1158/1538-7445.am2022-1359.
Texto completoKang, Sung Nam, Eunmyong Lee, Mi-Kyung Lee y Soo-Jeong Lim. "Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma". Drug Delivery 18, n.º 2 (14 de octubre de 2010): 143–49. http://dx.doi.org/10.3109/10717544.2010.522610.
Texto completoBoichuk, Sergei, Aigul Galembikova, Firuza Bikinieva, Pavel Dunaev, Aida Aukhadieva, Kirill Syuzov, Svetlana Zykova, Nazim Igidov, Alexander Ksenofontov y Pavel Bocharov. "2-APCAs, the Novel Microtubule Targeting Agents Active against Distinct Cancer Cell Lines". Molecules 26, n.º 3 (25 de enero de 2021): 616. http://dx.doi.org/10.3390/molecules26030616.
Texto completoSun, Yunpeng, Chonglin Tao, Fuxiang Yu, Wenjun Yang, Yunfeng Shan, Zhengping Yu, Hongqi Shi, Mengtao Zhou, Qiyu Zhang y Huanhuan Wu. "Discovery of a novel human lactate dehydrogenase A (LDHA) inhibitor as an anti-proliferation agent against MIA PaCa-2 pancreatic cancer cells". RSC Advances 6, n.º 28 (2016): 23218–22. http://dx.doi.org/10.1039/c5ra27736a.
Texto completoKIM, Jun Hyun, Joo Hee KIM, Gun Eui Lee, Sang Woong KIM y I. Kwon CHUNG. "Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells". Biochemical Journal 373, n.º 2 (15 de julio de 2003): 523–29. http://dx.doi.org/10.1042/bj20030363.
Texto completoKhattak, Shahana, Gul Rehman Elmi, Farah Azhar, Hina Ahsan, Kalsoom Saleem y Faryal Jahan. "Biological Applications of Magnetic Nanoparticles; A Review". Pharmaceutical Communications 1, n.º 01 (31 de diciembre de 2022): 07–29. http://dx.doi.org/10.55627/pharma.001.001.0200.
Texto completoAl-Radadi, Najlaa S. "Green Biosynthesis of Flaxseed Gold Nanoparticles (Au-NPs) as Potent Anti-cancer Agent Against Breast Cancer Cells". Journal of Saudi Chemical Society 25, n.º 6 (junio de 2021): 101243. http://dx.doi.org/10.1016/j.jscs.2021.101243.
Texto completoKaufman-Szymczyk, Agnieszka, Wiktoria Kaczmarek, Krystyna Fabianowska-Majewska y Katarzyna Lubecka-Gajewska. "Lunasin and Its Epigenetic Impact in Cancer Chemoprevention". International Journal of Molecular Sciences 24, n.º 11 (24 de mayo de 2023): 9187. http://dx.doi.org/10.3390/ijms24119187.
Texto completoZhang, Zhenqing, Yunli Jia, Xiaoniu Miao, Weifeng Huang, Chao Wang, Zhijun Yuan, Wenchao Jiang, Liandi Chen, Zhiyuan Li y Andy Tsun. "Abstract 5528: A highly potent anti-CD39 biparatopic antibody and bispecific for cancer therapy". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5528. http://dx.doi.org/10.1158/1538-7445.am2022-5528.
Texto completoOlgierd, Batoryna, Żyła Kamila, Banyś Anna y Morawiec Emilia. "The Pluripotent Activities of Caffeic Acid Phenethyl Ester". Molecules 26, n.º 5 (2 de marzo de 2021): 1335. http://dx.doi.org/10.3390/molecules26051335.
Texto completoSong, Jun-Hui, Juhee Park, Sung Lyea Park, Byungdoo Hwang, Wun-Jae Kim, Chan Lee y Sung-Kwon Moon. "A Novel Cyclic Pentadepsipeptide, N-Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer". Cancers 13, n.º 2 (7 de enero de 2021): 191. http://dx.doi.org/10.3390/cancers13020191.
Texto completoSong, Jun-Hui, Juhee Park, Sung Lyea Park, Byungdoo Hwang, Wun-Jae Kim, Chan Lee y Sung-Kwon Moon. "A Novel Cyclic Pentadepsipeptide, N-Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer". Cancers 13, n.º 2 (7 de enero de 2021): 191. http://dx.doi.org/10.3390/cancers13020191.
Texto completoKannan, Arvind, Navam Hettiarachchy y Satya Narayan. "Colon and Breast Anti-cancer Effects of Peptide Hydrolysates Derived from Rice Bran". Open Bioactive Compounds Journal 2, n.º 1 (16 de abril de 2009): 17–20. http://dx.doi.org/10.2174/1874847300902010017.
Texto completoDing, Zhongpeng, Hejuan Cheng, Shixiao Wang, Yingwei Hou, Jianchun Zhao, Huashi Guan y Wenbao Li. "Development of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent". Bioorganic & Medicinal Chemistry Letters 27, n.º 6 (marzo de 2017): 1416–19. http://dx.doi.org/10.1016/j.bmcl.2017.01.096.
Texto completoKrutilina, Raisa I., Kelli L. Hartman, Damilola Oluwalana, Hilaire C. Playa, Deanna N. Parke, Hao Chen, Duane D. Miller, Wei Li y Tiffany N. Seagroves. "Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis". Cancers 14, n.º 21 (29 de octubre de 2022): 5336. http://dx.doi.org/10.3390/cancers14215336.
Texto completoSasmal, Sanjita, Sukanya Patra, Venkatesham Boorgu, Shankar Chithaluri, Mahesh Yanamadra, Deepika Hiremath, Hemashankar Pathange et al. "Abstract 6369: Discovery of potent, orally bioavailable, brain penetrant RAD51 inhibitor as an anti-cancer agent". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 6369. http://dx.doi.org/10.1158/1538-7445.am2022-6369.
Texto completoLyu, Yuan, Steven Kopcho, Folnetti A. Alvarez, Bryson C. Okeoma y Chioma M. Okeoma. "Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead". Cancers 12, n.º 9 (28 de agosto de 2020): 2448. http://dx.doi.org/10.3390/cancers12092448.
Texto completoViswanadha, Srikant, Satyanarayana Eleswarapu, Kondababu Rasamsetti, Haritha Polimati, Sridhar Veeraraghavan y Swaroop Vakkalanka. "Abstract 5493: Activity of RP12146, a novel, selective, and potent small molecule inhibitor of PARP 1/2, in solid tumors". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5493. http://dx.doi.org/10.1158/1538-7445.am2022-5493.
Texto completoCui, Qingbin, Wenwen Ding, Panpan Liu, Bingling Luo, Jing Yang, Wenhua Lu, Yumin Hu, Peng Huang y Shijun Wen. "Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells". International Journal of Molecular Sciences 23, n.º 20 (12 de octubre de 2022): 12169. http://dx.doi.org/10.3390/ijms232012169.
Texto completoJiang, Linlin, Lei Zhang y Xinran Zhang. "Eupalinilide B as a novel anti-cancer agent that inhibits proliferation and epithelial–mesenchymal transition in laryngeal cancer cells". Journal of International Medical Research 50, n.º 1 (enero de 2022): 030006052110679. http://dx.doi.org/10.1177/03000605211067921.
Texto completoFlick, Hollie E., Judith M. LaLonde, William P. Malachowski y Alexander J. Muller. "The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1". International Journal of Tryptophan Research 6 (enero de 2013): IJTR.S12094. http://dx.doi.org/10.4137/ijtr.s12094.
Texto completoMittraphab, Yanisa, Nattaya Ngamrojanavanich, Kuniyoshi Shimizu, Kiminori Matsubara y Khanitha Pudhom. "Anti-Angiogenic Activity of Rotenoids from the Stems of Derris trifoliata". Planta Medica 84, n.º 11 (18 de enero de 2018): 779–85. http://dx.doi.org/10.1055/s-0044-100797.
Texto completoChen, Liping, Di Feng, Yafang Qian, Xiao Cheng, Huizhu Song, Yifan Qian, Xu Zhang et al. "Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling". Phytomedicine 85 (mayo de 2021): 153537. http://dx.doi.org/10.1016/j.phymed.2021.153537.
Texto completoDhakal, Bimala, Yoko Tomita, Paul Drew, Timothy Price, Guy Maddern, Eric Smith y Kevin Fenix. "Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects". Molecules 28, n.º 8 (21 de abril de 2023): 3624. http://dx.doi.org/10.3390/molecules28083624.
Texto completoKrishnan, Aruna V. y David Feldman. "Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment". Endocrine-Related Cancer 17, n.º 1 (marzo de 2010): R19—R38. http://dx.doi.org/10.1677/erc-09-0139.
Texto completoHemalatha, C. N. y A. M. Vijey. "3D QSAR AND DOCKING STUDY OF PERYLENE - DI IMIDES ANALOGUES AS POTENT APOPTOSIS INDUCER AND EFFICACIOUS ANTICANCER AGENT". INDIAN DRUGS 54, n.º 12 (28 de diciembre de 2017): 15–27. http://dx.doi.org/10.53879/id.54.12.11012.
Texto completoShin, Seulgi, Sungsu Lim, Ji Yeon Song, Dohee Kim, Min Jeong Choi, Changdev G. Gadhe, A. Young Park, Ae Nim Pae y Yun Kyung Kim. "Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent". Pharmaceutics 11, n.º 10 (28 de septiembre de 2019): 497. http://dx.doi.org/10.3390/pharmaceutics11100497.
Texto completoHarakeh, Steve, Mohammed S. Almuhayawi, Isaac O. Akefe, Saber H. Saber, Soad K. Al Jaouni, Torki Alzughaibi, Yousef Almehmadi, Soad Shaker Ali, Dhruba J. Bharali y Shaker Mousa. "Novel Pomegranate-Nanoparticles Ameliorate Cisplatin-Induced Nephrotoxicity and Improves Cisplatin Anti-Cancer Efficacy in Ehrlich Carcinoma Mice Model". Molecules 27, n.º 5 (28 de febrero de 2022): 1605. http://dx.doi.org/10.3390/molecules27051605.
Texto completoHu, Pengchao, Ying Wang, Yan Zhang, Hui Song, Fangfang Gao, Hongyi Lin, Zhihao Wang, Lei Wei y Fang Yang. "Novel mononuclear ruthenium(ii) complexes as potent and low-toxicity antitumour agents: synthesis, characterization, biological evaluation and mechanism of action". RSC Advances 6, n.º 36 (2016): 29963–76. http://dx.doi.org/10.1039/c6ra02571d.
Texto completoKo, Jong-Hee, Hyuk-Sang Kwon, Bomin Kim, Gihong Min, Chorong Shin, Seok-Woo Yang, Seong Wook Lee, Youngmin Lee, Dahae Hong y Yong-Sung Kim. "Preclinical Efficacy and Safety of an Anti-Human VEGFA and Anti-Human NRP1 Dual-Targeting Bispecific Antibody (IDB0076)". Biomolecules 10, n.º 6 (17 de junio de 2020): 919. http://dx.doi.org/10.3390/biom10060919.
Texto completoBooth, Brian W., Beau D. Inskeep, Hiral Shah, Jang Pyo Park, Elizabeth J. Hay y Karen J. L. Burg. "Tannic Acid Preferentially Targets Estrogen Receptor-Positive Breast Cancer". International Journal of Breast Cancer 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/369609.
Texto completoChen, Ruie, Jinming Zhang, Yangyang Hu, Shengpeng Wang, Meiwan Chen y Yitao Wang. "Potential Antineoplastic Effects of Aloe-emodin: A Comprehensive Review". American Journal of Chinese Medicine 42, n.º 02 (enero de 2014): 275–88. http://dx.doi.org/10.1142/s0192415x14500189.
Texto completo